| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/27/2010 | US7763771 transgenic plants that display an improved oil quantity phenotype or an improved meal quality phenotype due to altered gen expression of an improved meal quality (IMQ) nucleic acid |
| 07/27/2010 | US7763722 Small interference RNA gene therapy |
| 07/27/2010 | US7763718 Free of transmembrane domain; immunoglobulins; autoimmune diseases |
| 07/27/2010 | US7763713 heterodimeric receptor complex comprising a receptor polypeptide and a interleukin-2 gamma receptor polypeptide, used for detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells in vitro and in vivo; antibodies; immunology |
| 07/27/2010 | US7763712 Bone delivery conjugates and method of using same to target proteins to bone |
| 07/27/2010 | US7763711 Consisting of the amino acid sequence SVASTITGV, the peptide having the ability to bind to a molecule of human major histocompatibility complex class-I; use in immunotherapy of tumor-associated diseases and/or adenomatous diseases |
| 07/27/2010 | US7763705 Viral peptides for use in activating immune response to treat and prevent viral infection |
| 07/27/2010 | US7763590 Nucleotide sequence complementary to wild-type gene; Rna strand which prevents gene expression |
| 07/27/2010 | US7763589 Administering a vector construct that expresses an immunogenic portion of an antigen derived from a pathogen, and administering an immunogenic protein of said antigen, to generate an immune response |
| 07/27/2010 | US7763586 Melanoma antigens and their use in diagnostic and therapeutic methods |
| 07/27/2010 | US7763466 Generating cells for cell replacement therapy |
| 07/27/2010 | US7763464 Generating cardiomyocytes from primate pluripotent stem cells via incubation in tissues which demonstrate spontaneous contraction, culture, separate and recover fractions which express cardiac marker proteins |
| 07/27/2010 | US7763463 Use of cyclic AMP and ascorbic acid to produce dopaminergic neurons from embryonic stem cells |
| 07/27/2010 | US7763459 decellularization of an isolated tissue using solubilizing solutions comprising oxidizing agents, while substantially maintaining the biological, mechanical and biochemical properties of the matrices |
| 07/27/2010 | US7763458 Vector system for plants |
| 07/27/2010 | US7763452 Purification of HER-2 variants |
| 07/27/2010 | US7763449 Bioactive ribonucleases for treating tumors in humans |
| 07/27/2010 | US7763447 Method of producing succinic acid with bacterium comprising a modified fumarate reductase gene or a modified succinate dehydrogenase gene |
| 07/27/2010 | US7763446 nucleic acids encoding a chimeric protein comprising a cleavage domain and a composite nucleic acid-binding region, that comprises at least two component polypeptide portions which are individually capable of binding specific nucleotide sequences |
| 07/27/2010 | US7763445 Dimeric fusion proteins and materials and methods for producing them |
| 07/27/2010 | US7763444 Koji mold-origin phospholipase A2 |
| 07/27/2010 | US7763443 Expression vector comprising nucleotide sequences coding green fluorescent protein for use as reporter molecule in gene expression analysis |
| 07/27/2010 | US7763431 screening for modulators and can be used as flavor additives in compositions for human or animal consumption |
| 07/27/2010 | US7763422 evaluating the amount of cancer cells existing in pancreatic cells or tissues, by measuring the methylation frequency of Fibrillin2 gene or an index value having the correlation therewith, and comparing with a control; medical diagnosis |
| 07/27/2010 | US7763262 Attenuated yiaO mutants of Pasteurellaceae bacteria |
| 07/27/2010 | US7763258 Used to assess protein binding interactions |
| 07/27/2010 | US7763254 Human immunodeficiency virus integrase-LEDGF p75 isoform protein-protein interactions |
| 07/27/2010 | US7763250 Antibodies directed against amyloid-beta peptide and nucleic acids encoding same |
| 07/27/2010 | US7763249 Brain protein specific immunoglobulin for use in diagnosis, prevention and treatment of alzheimer's disease |
| 07/27/2010 | US7763248 Humanized collagen antibodies and related methods |
| 07/27/2010 | US7763243 Arming of activated T cells with BiAbs increases the effective precursor frequency of CTL in the cancer patient. |
| 07/27/2010 | CA2624375C Nucleic acid molecules encoding enzymes from wheat which are involved in starch synthesis |
| 07/27/2010 | CA2519282C Development of a preventive vaccine for filovirus infection in primates |
| 07/27/2010 | CA2477163C Soluble form of carbonic anhydrase ix (s-ca-ix), assays to detect s-ca ix, and ca ix's coexpression with her-2/neu/c-erbb-2, and ca ix-specific monoclonal antibodies to non-immunodominant epitopes |
| 07/27/2010 | CA2430112C Paramyxovirus vector encoding angiogenesis gene and use thereof |
| 07/27/2010 | CA2422440C Oligonucleotide sequence formula for labeling oligonucleotide probes and proteins for in situ analysis |
| 07/27/2010 | CA2420717C Artificial intelligence system for genetic analysis |
| 07/27/2010 | CA2413475C Zap-70 expression as a marker for chronic lymphocytic leukemia/small lymphocytic lymphoma (cll/sll) |
| 07/27/2010 | CA2404000C A functional assay of high-density lipoprotein |
| 07/27/2010 | CA2385937C Method to improve the stability and broaden the ph range of family g/11 xylanases |
| 07/27/2010 | CA2375820C The myostatin gene promoter and inhibition of activation thereof |
| 07/27/2010 | CA2375027C High specificity primers, amplification methods and kits |
| 07/27/2010 | CA2368944C Paramyxovirus-derived rnp |
| 07/27/2010 | CA2339870C Antithrombin nucleotides and proteins from horn fly |
| 07/27/2010 | CA2338989C Antibodies for detecting microorganisms |
| 07/27/2010 | CA2332829C Vaccine delivery system |
| 07/27/2010 | CA2323091C Nephrin gene and protein |
| 07/27/2010 | CA2304927C Method of site-specific insertion in zymomonas mobilis |
| 07/27/2010 | CA2301902C Novel extracellular serine protease |
| 07/27/2010 | CA2263152C Immunologically active proteins from borrelia burgdorferi, nucleic acids which encode them, and their use in test kits and as vaccines |
| 07/27/2010 | CA2237717C Screening assay for compounds stimulating somatostatin and insulin production |
| 07/27/2010 | CA2236982C The use of lecithin-cholesterol acyltransferase (lcat) in the treatment of atherosclerosis |
| 07/27/2010 | CA2224080C Relaxin-like factor and methods and uses thereof |
| 07/27/2010 | CA2223300C Expression of lipoproteins |
| 07/27/2010 | CA2221468C Upstream activator sequences and recombinant promoter sequences functional in yarrowia and vectors containing them |
| 07/27/2010 | CA2195385C An artificial recombinant substrate (ragg 1) and native aggrecan to study the proteolytic activity of 'aggrecanase' in cell culture systems |
| 07/23/2010 | CA2691041A1 Protein mixtures for maize insect control |
| 07/22/2010 | WO2010083504A2 Therapeutic charge engineered variants of lysozyme and methods for using same to treat infections |
| 07/22/2010 | WO2010083253A2 Cd47 related compositions and methods for treating immunological diseases and disorders |
| 07/22/2010 | WO2010083250A2 Single-cell nucleic acid analysis |
| 07/22/2010 | WO2010083225A2 Targeted cryptosporidium biocides |
| 07/22/2010 | WO2010083203A2 Non-embryonic stem cells and uses thereof |
| 07/22/2010 | WO2010083178A1 Isolated novel nucleic acid and protein molecules from corn and methods of using those molecules to generate transgenic plants with enhanced agronomic traits |
| 07/22/2010 | WO2010083046A2 Methods for using next generation sequencing to identify 5-methyl cytosines in the genome |
| 07/22/2010 | WO2010083044A1 Diagnosis and treatment of autism spectrum disorders |
| 07/22/2010 | WO2010082903A1 Method of inhibiting proliferation of hepatic stellate cells |
| 07/22/2010 | WO2010082804A2 Method for producing physiologically active protein or peptide using immunoglobulin fragment |
| 07/22/2010 | WO2010082640A1 Enzymatic preparation containing thermostable dna polymerase, process for producing same, and method for detecting analyte organism |
| 07/22/2010 | WO2010082631A1 Process for producing nucleic acid sample, and process for producing nucleic acid amplification product using the nucleic acid sample |
| 07/22/2010 | WO2010082622A1 NOVEL HIGH-FUNCTION ENZYME OBTAINED BY ALTERING SUBSTRATE SPECIFICITY OF HUMAN β-HEXOSAMINIDASE Β |
| 07/22/2010 | WO2010082619A1 High expression promoter and method for producing gene product using same |
| 07/22/2010 | WO2010082572A1 Novel expression vector |
| 07/22/2010 | WO2010082385A1 Mouse having human hepatocytes transplanted therein |
| 07/22/2010 | WO2010082097A2 Fusion proteins the process to preparation and utilization in expression systems of recombinant proteins |
| 07/22/2010 | WO2010081971A1 Identification of novel antagonist toxins of t-type calcium channel for analgesic purposes |
| 07/22/2010 | WO2010081917A1 Genes regulating plant branching, promoters, genetic constructs containing same and uses thereof |
| 07/22/2010 | WO2010081875A1 A recombinant alpha-hemolysin polypeptide of staphylococcus aureus, having a deletion in the stem domain and heterologous sequences inserted |
| 07/22/2010 | WO2010081842A2 METHODS AND KITS TO GENERATE miRNA- AND small RNA-EXPRESSING VECTORS, AND ITS APPLICATION TO DEVELOP LENTIVIRAL EXPRESSION LIBRARIES |
| 07/22/2010 | WO2010081741A1 A method for increasing protein expression in cells |
| 07/22/2010 | WO2010081494A1 A method of increasing protein expression in eukaryotic cells |
| 07/22/2010 | WO2010081282A1 Gene cluster for thuringiensin synthesis |
| 07/22/2010 | WO2010062604A3 Models of thrombotic thrombocytopenic purpura and methods of use thereof |
| 07/22/2010 | WO2010061186A3 Method for the transformation of plant cell plastids |
| 07/22/2010 | WO2010059616A3 Biocatalysts and methods for conversion of hemicellulose hydrolsates to biobased products |
| 07/22/2010 | WO2010059004A9 Chemical inhibitor of p53-snail binding and pharmaceutical composition for treating cancer disease containing same as its active ingredient |
| 07/22/2010 | WO2010053518A3 Methods and compositions for inactivating glutamine synthetase gene expression |
| 07/22/2010 | WO2010051502A3 Light targeting molecules and uses thereof |
| 07/22/2010 | WO2010049897A3 Isolated polynucleotides and polypeptides and methods of using same for increasing plant yield |
| 07/22/2010 | WO2010040770A3 Methods for identifying potential cyp4z1 metabolites, inhibitors or prodrugs |
| 07/22/2010 | WO2010040023A3 Methods and compositions for protein delivery |
| 07/22/2010 | WO2010038965A3 GCH1-TARGETED si RNA, RECOMBINANT VECTOR CONTAINING si RNA, AND PHARMACEUTICAL COMPOSITION CONTAINING RECOMBINANT VECTOR FOR TREATING AND PREVENTING NEUROPATHIC PAIN |
| 07/22/2010 | WO2010037063A3 Plasmodium vaccines, antigens, compositions and methods |
| 07/22/2010 | WO2010036856A3 Compatible display vector systems |
| 07/22/2010 | WO2010033923A3 Genus-wide chlamydial peptide vaccine antigens |
| 07/22/2010 | WO2010025310A3 Methods and devices for high fidelity polynucleotide synthesis |
| 07/22/2010 | WO2010020941A3 Isolated polypeptides and polynucleotides useful for increasing nitrogen use efficiency, abiotic stress tolerance, yield and biomass in plants |
| 07/22/2010 | WO2010019813A3 Production of fatty actds by genetically modified photosynthetic organisms |
| 07/22/2010 | WO2010017230A3 Methods, systems and compositions related to microbial bio-production of butanol and/or isobutanol |
| 07/22/2010 | WO2010003225A8 Influenza virus-like particles (vlps) comprising hemagglutinin |
| 07/22/2010 | WO2010002966A3 High throughput screening method and use thereof to identify a production platform for a multifunctional binding protein |